Paul Beckett Selected Research

norlaudanosoline-1-carboxylic acid (NLCA)

1/2019	Impact of organisation and specialist service delivery on lung cancer outcomes.
7/2017	Apples and pears? A comparison of two sources of national lung cancer audit data in England.
9/2016	Patient characteristics, treatment and survival in pulmonary carcinoid tumours: an analysis from the UK National Lung Cancer Audit.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul Beckett Research Topics

Disease

7	Lung Neoplasms (Lung Cancer) 06/2021 - 09/2016
2	Neoplasms (Cancer) 06/2021 - 01/2020
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2017 - 01/2017
1	Adenocarcinoma 06/2021
1	Carcinoma (Carcinomatosis) 06/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2019
1	Asthma (Bronchial Asthma) 01/2018
1	Inflammation (Inflammations) 01/2018
1	Hypersensitivity (Allergy) 07/2003

Drug/Important Bio-Agent (IBA)

3	norlaudanosoline-1-carboxylic acid (NLCA)IBA 01/2019 - 09/2016
2	Phosphotransferases (Kinase)IBA 11/2019 - 01/2017
2	apilimodIBA 06/2017 - 01/2017
1	B7-H1 AntigenIBA 06/2021
1	Tyrosine Kinase InhibitorsIBA 06/2021
1	Biomarkers (Surrogate Marker)IBA 06/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2019
1	Immunoglobulin E (IgE)IBA 01/2018
1	ChitinasesIBA 01/2018
1	Cytotoxins (Cytolysins)IBA 06/2017
1	LipidsIBA 01/2017
1	alpha-AmylasesIBA 07/2003
1	EnzymesIBA 07/2003

Therapy/Procedure

3	Radiotherapy 06/2021 - 01/2020
2	Drug Therapy (Chemotherapy) 06/2021 - 01/2020
2	Therapeutics 06/2021 - 01/2018
1	Continuity of Patient Care 06/2021